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Epstein-Barr virus (EBV) was recovered from cerebrospinal cells (but not from cell-free
fluid) of a patient with meningoencephalitis complicating infectious mononucleosis. This find-
ing suggests that virus-altered B lymphocytes can invade the central nervous system and may
play a direct role in the pathogenesis of neurologic sequelae of EBV infections. Several
mechanisms by which these cells can cause neurologic manifestations are discussed.
Neurologic complications of primary Epstein-Barr virus (EBV) infections with
and without a heterophil antibody response include aseptic meningitis, men-
ingoencephalitis, myelitis, Guillain-Barre syndrome, and Bell's palsy [1,2,3]. The
pathogenesis of these infrequent complications is not understood. Antibodies to
EBV-viral capsid antigen (EBV-VCA) have been demonstrated in cerebrospinal fluid
in a few cases ofmononucleosis-associated meningoencephalitis [2,3]. Virus has also
been detected in the CSF of a patient with infectious mononucleosis and encephalitis
[4]. In this report, we describe a patient with infectious mononucleosis who
presented with acute meningoencephalitis and in whom EBV was demonstrated in
the cells of the CSF.
REPORT OF A CASE
A 23-year-old white female developed the insidious onset of bifrontal headache
and malaise without antecedent pharyngitis, upper respiratory infection, or lymph-
adenopathy. After ten days the headache acutely worsened and she became disori-
ented and confused. On admission to the New York Hospital she was initially
delirious, incoherent, agitated, and finally stuporous. The patient exhibited spon-
taneous conjugated roving eye movements, multifocal myoclonic jerks, and in-
creased motor tone with paratonia more marked on the left. There was diffuse
hyperreflexia with an extensor plantar response on the left. The neck was stiff. Her
temperature on admission was 38.5°C. There was no pharyngitis, lymphade-
nopathy, or splenomegaly. The hematocrit was 38.3 and the white cell count was
6300 cells/mm3 with 36 percent lymphocytes and 12 percent atypical lymphocytes.
Routine blood chemistries and liver function tests were normal. Lumbar puncture
performed on admission showed an opening pressure of260 mm H20. The fluid was
clear and colorless with 1 RBC/mm3, 23 mononuclear cells/mm3; glucose was
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All rights of reproduction in any form reserved.60 mgm percent and protein was 107 mg percent. The serum heterophil-antibody
titer was 1:896 before and after guinea-pig kidney absorption and negative after
beef-cell absorption. The electroencephalogram was disorganized with intermittent
theta and 11/2-3 Hz delta activity seen synchronously and asynchronously from each
hemisphere. Computerized tomographic brain scan prior to and after the injection
of contrast medium was normal. By the third hospital day she was more responsive,
able to follow commands, but was still disoriented and somewhat somnolent. There
was paratonia and an extensor plantar response on the left. Repeat lumbar puncture
revealed an opening pressure of 180 mm H20 with 0 RBC/mm3, 8 lymphocytes/
mm3; CSF glucose was 74 mg percent and CSF protein was 113 mg percent. Her
neurological status continued to improve and by the sixth hospital day she was alert
and oriented, motor tone was normal, and she had bilateral flexor plantar
responses. At this time posterior cervical nodes were first noted to be enlarged
bilaterally and the spleen tip was palpable. Lumbar puncture on the sixth hospital
day (sixteenth day of illness) revealed an opening pressure 130 mm H20 with 1
RBC/mm3; 16 lymphocytes/mm3; CSF glucose was 70 and CSF protein was 105 mg
percent. Serum heterophil titer had risen to 1:3584. Heterophil-antibody was not
detectable in the CSF on either the third or sixth hospital day. The patient remained
afebrile and was discharged on the fourteenth hospital day with a normal neuro-
logical exam.
Antibody titers to the EBV-viral capsid antigen (VCA) were measured in sera and
cerebrospinal fluid specimens by indirect immunofluorescence [5]. The laboratory
data are summarized in Table 1. By the sixth hospital day (sixteenth of illness) the
EBV-VCA titer in serum was 1:160 and the CSF titer remained 1:10. Tests for an-
tibodies to CMV, herpes simplex, measles, mumps, and Coxsackie B1-B6 viruses
were non-diagnostic in the sera and negative in the CSF.
CSF obtained on the sixteenth day ofillness was tested for the presence ofEBV by
the leukocyte transformation assay [6]. In order to distinguish whether virus, ifpres-
ent, was extracellular or cell-associated, approximately 5 ml of CSF was centri-
fuged to sediment the cells. Replicate cultures containing 0.4 ml of umbilical cord
blood lymphocytes were inoculated with 0.1 ml of cell-free CSF or with 0.1 ml of a
suspension of approximately 1.6 x 104 cells. The cultures were maintained and ob-
served for the appearance of EBV induced transformation for eight weeks. Four of
TABLE I
Summary of Laboratory Data
Day After Onset of Illness
10 13 16 23
Serum heterophil antibody (absorbed) 1:896 NT* 1:3584 1:3584
CSF heterophil antibody NT Neg Neg NT
EBV-VCA antibody
serum 1:10 1:10 1:40 1:160
CSF Neg Neg 1:10 1:10
Isolation of EBV from CSF
CSF cells NT NT Yes NT
Cell-free CSF NT NT No NT
CSF cell count** 23/mm3 8/mm3 16/mm3 18/mm3
*NT: not tested.
**mononuclear cells; morphology not further characterized.
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four lymphocyte cultures inoculated with CSF cells transformed while none of the
four cultures inoculated with cell-free CSF transformed. The presence of EB viral
genome in the transformed cells was confirmed by the demonstration of the EBV
nuclear antigen (EBNA) in the cells [7].
DISCUSSION
When meningoencephalitis complicates infectious mononucleosis, it is often the
presenting and major manifestation of disease, as it was in the present case [8]. The
relationship of this patient's disease to a primary EBV infection was clearly
established by the diagnostic rise in EBV-VCA antibody titer, the heterophil-
antibody response, and the presence of EBV-VCA antibody in the CSF. The finding
which prompted this report was the demonstration that EBV was present in cells in
the spinal fluid. Recovery of EBV from spinal fluid during EBV-associated
encephalitis has been reported in only one other case [4]. In that instance cells and
fluid were not cultured separately; thus it was not possible to determine whether the
virus was cell-free or cell-associated.
B cells infected with EBV are present in the circulation duringIM [9]. These cells
express EBNA, carry the complete EBV genome, and exhibit proliferative and in-
filtrative properties [10,11]. Indeed, in individuals with certain immunodeficiencies
these same EBNA-positive cells can cause disseminated polyclonal B cell lymphoma
[11]. Therefore, it seems reasonable to propose that the infected cells detected in the
spinal fluid of our patient had actively invaded the central nervous system. Although
ultimately derived from the circulation, these cells were not contaminants from
blood, as the lumbar puncture was not traumatic. EBV-infected cells in peripheral
blood do not appear to express lytic viral functions in vivo, but when placed in
culture undergo lytic viral replication [9]. Infectious virus released from these cells in
vitro can then transform normal B cells which, in the assay used here, were provided
by inclusion of cord blood lymphocytes in the culture. This mechanism probably ac-
counts for the recovery of virus from spinal fluid cells in the present case. The
failure to isolate virus from cell-free fluid may indicate the absence of infectious par-
ticles but neutralizing antibody, if present in the fluid, could have prevented virus
isolation. Unfortunately we did not test for this possibility.
Antibodies to EBV-VCA were present in the spinal fluid of our patient and have
been found in CSF of patients with EBV-associated encephalitis [2] and cerebellar
ataxia [3]. Because in each case the serum/CSF ratio of EBV antibodies was low and
other serum antibodies were absent from the CSF, it has been suggested that the
VCA antibodies were produced within the central nervous system in response to lo-
cally inciting antigen [2,3]. Since EBV-VCA is a structural component of the virus
and is expressed in lytically infected cells [5], such an interpretation implies that ac-
tive viral replication occurs within the central nervous system. However, it should be
noted that in none of the cases reported thus far have rigorous criteria, such as those
proposed by Christensen et al. [12], been used to show conclusively that these an-
tibodies were made within the central nervous system. Also it has not yet been shown
that antibody production within the central nervous system constitutes unequivocal
evidence that the inciting antigen is present there. Nevertheless these considerations
raise the possibility that cells harboring the EBV genome in a latent form in the
blood might undergo lytic viral replication after penetrating the blood-brain barrier.
This notion is also compatible with our results, since infectious virus produced by
the herpes viruses tend to remain cell-associated and the release of small amounts of
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cell-free virus might escape detection due to adsorption to cells with virus receptors
or to neutralization by antibody.
The invasion of the central nervous system by EBV-infected cells may be an im-
portant event in the pathogenesis ofmeningoencephalitis complicating primary EBV
infection, although how these cells are involved in causing neurologic manifestations
is at present a matter of speculation. Infected cells may infiltrate neural tissue lo-
cally, causing dysfunction directly, or they may stimulate a local inflammatory reac-
tion which secondarily causes symptoms. Alternatively infectious virus released by
cells that have penetrated the blood-brain barrier may infect cells within neural tissue.
The strict tropism of EBV for B lymphocytes in vitro [131 makes this eventuality
seem unlikely but it cannot be ruled out altogether. Recent evidence that salivary
tissue is the site ofprimary viral replication in IM raises the possibility that EBV may
be able to infect certain types of nonlymphoid cells in vivo [14]. Subtle involvement
of the central nervous system during IM may be common, as Niederman [15] has
shown that mild spinal fluid pleocytosis occurs in patients with headache. Ifsome of
these cells carry EBV as in the case reported here, invasion ofthe nervous system by
infected cells may be a common event which only occasionally results in significant
neurological disease. The factors that determine which patients with EBV infection
develop clinically apparent neurologic sequelae remain unknown.
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